Qureshi, N. ., Woods, B. ., de Faria, N. ., Goncalves, S. ., Cox, E. ., Bee, L. ., … Kai, J. . (2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1–140. http://doi.org/10.3310/ctmd0148
Heart Disease Risk Factors
Yu, D. ., Huang, X. ., Mamas, M. A., & Wilkie, R. . (2023). Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017. RMD Open, 9. http://doi.org/10.1136/rmdopen-2023-003298
Livingstone, S. ., Morales, D. R., Fleuriot, J. ., Donnan, P. T., & Guthrie, B. . (2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. BMC Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
Conrad, N. ., Verbeke, G. ., Molenberghs, G. ., Goetschalckx, L. ., Callender, T. ., Cambridge, G. ., … . Y. Verbakel, J. . (2022). Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet, 400, 733–743. http://doi.org/10.1016/s0140-6736(22)01349-6
Dziopa, K. ., Asselbergs, F. W., Gratton, J. ., Chaturvedi, N. ., & Schmidt, A. F. (2022). Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia, 65, 644–656. http://doi.org/10.1007/s00125-021-05640-y